Covering material



The covering material can in particular embodiments be a transdermal therapeutic system (including comprising a therapeutic agent such as fentanyl) and comprising a face (e.g. face sheet or top layer) with imprint including a line, which can be continuous or dashed, which imprint can be suitably provided e.g. by a removable film.

FIG. 1 is a front view of the covering material in a first embodiment;

FIG. 2 is a front view of the covering material in a second embodiment;

FIG. 3 is a front view of the covering material in a third embodiment;

FIG. 4 is a front view of the covering material in a fourth embodiment;

FIG. 5 is a front view of the covering material in a five embodiment;

FIG. 6 is a front view of the covering material in a sixth embodiment;

FIG. 7 is a front view of the covering material in a seventh embodiment;

FIG. 8 is a front view of the covering material in a eighth embodiment;

FIG. 9 is a front view of the covering material in a ninth embodiment;

FIG. 10 is a front view of the covering material in a tenth embodiment;

FIG. 11 is a front view of the covering material in an eleventh embodiment;

FIG. 12 is a front view of the covering material in a twelfth embodiment;

FIG. 13 is a front view of the covering material in a thirteenth embodiment;

FIG. 14 is a front view of the covering material in a fourteenth embodiment; and,

FIG. 15 is a front view of the covering material in a fifteenth embodiment.

In FIGS. 1–15, the outer broken lines represent the external dimensions of the transdermal therapeutic system and does not make up part of the subject design. That is, the subject design is flat. The sides and back of the covering material are not claimed.

The broken lines shown in the internal portion of the covering material represent a continuous or dashed line which is ornamental and is included as part of the claimed design. 

The ornamental design for a covering material, as shown and described. 